BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis
FRA:BRYN • US0846707026
426.45 EUR
+3.15 (+0.74%)
Last: Feb 27, 2026, 07:00 PM
Taking everything into account, BRYN scores 5 out of 10 in our fundamental rating. BRYN was compared to 56 industry peers in the Financial Services industry. BRYN scores excellent on profitability, but there are some minor concerns on its financial health. BRYN is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, BRYN could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
- In the past year BRYN was profitable.
- In the past year BRYN had a positive cash flow from operations.
- Of the past 5 years BRYN 4 years were profitable.
- In the past 5 years BRYN always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 5.50%, BRYN belongs to the top of the industry, outperforming 82.14% of the companies in the same industry.
- With a decent Return On Equity value of 9.66%, BRYN is doing good in the industry, outperforming 67.86% of the companies in the same industry.
- BRYN has a Return On Invested Capital of 4.53%. This is in the better half of the industry: BRYN outperforms 60.71% of its industry peers.
- BRYN had an Average Return On Invested Capital over the past 3 years of 4.13%. This is below the industry average of 8.48%.
- The last Return On Invested Capital (4.53%) for BRYN is above the 3 year average (4.13%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.5% | ||
| ROE | 9.66% | ||
| ROIC | 4.53% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
1.3 Margins
- BRYN has a Profit Margin of 18.13%. This is in the better half of the industry: BRYN outperforms 75.00% of its industry peers.
- In the last couple of years the Profit Margin of BRYN has declined.
- The Operating Margin of BRYN (16.72%) is better than 60.71% of its industry peers.
- In the last couple of years the Operating Margin of BRYN has grown nicely.
- With a Gross Margin value of 17.71%, BRYN perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
- In the last couple of years the Gross Margin of BRYN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.72% | ||
| PM (TTM) | 18.13% | ||
| GM | 17.71% |
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BRYN is still creating some value.
- The number of shares outstanding for BRYN has been reduced compared to 1 year ago.
- Compared to 5 years ago, BRYN has less shares outstanding
- BRYN has a better debt/assets ratio than last year.
2.2 Solvency
- BRYN has an Altman-Z score of 1.36. This is a bad value and indicates that BRYN is not financially healthy and even has some risk of bankruptcy.
- BRYN has a Altman-Z score (1.36) which is in line with its industry peers.
- BRYN has a debt to FCF ratio of 6.58. This is a slightly negative value and a sign of low solvency as BRYN would need 6.58 years to pay back of all of its debts.
- BRYN has a better Debt to FCF ratio (6.58) than 67.86% of its industry peers.
- BRYN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
- With a decent Debt to Equity ratio value of 0.18, BRYN is doing good in the industry, outperforming 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 6.58 | ||
| Altman-Z | 1.36 |
ROIC/WACC1.41
WACC3.22%
2.3 Liquidity
- BRYN has a Current Ratio of 1.33. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
- BRYN's Current ratio of 1.33 is in line compared to the rest of the industry. BRYN outperforms 57.14% of its industry peers.
- BRYN has a Quick Ratio of 1.11. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
- BRYN has a Quick ratio (1.11) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.11 |
3. Growth
3.1 Past
- BRYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.97%, which is quite good.
- The Earnings Per Share has been growing by 17.78% on average over the past years. This is quite good.
- The Revenue has been growing slightly by 0.60% in the past year.
- BRYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.84% yearly.
EPS 1Y (TTM)17.97%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%33.51%
Revenue 1Y (TTM)0.6%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%2.13%
3.2 Future
- BRYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.26% yearly.
- Based on estimates for the next years, BRYN will show a small growth in Revenue. The Revenue will grow by 4.89% on average per year.
EPS Next Y-0.33%
EPS Next 2Y0.31%
EPS Next 3Y1.09%
EPS Next 5Y2.26%
Revenue Next Year0.8%
Revenue Next 2Y0.25%
Revenue Next 3Y1.4%
Revenue Next 5Y4.89%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 0.01, the valuation of BRYN can be described as very cheap.
- Based on the Price/Earnings ratio, BRYN is valued cheaper than 100.00% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.10, BRYN is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 0.02, the valuation of BRYN can be described as very cheap.
- Based on the Price/Forward Earnings ratio, BRYN is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
- When comparing the Price/Forward Earnings ratio of BRYN to the average of the S&P500 Index (28.06), we can say BRYN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.01 | ||
| Fwd PE | 0.02 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 92.86% of the companies listed in the same industry.
- BRYN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BRYN is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.04 | ||
| EV/EBITDA | 0.64 |
4.3 Compensation for Growth
- BRYN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y0.31%
EPS Next 3Y1.09%
5. Dividend
5.1 Amount
- No dividends for BRYN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:BRYN (2/27/2026, 7:00:00 PM)
426.45
+3.15 (+0.74%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-01 2025-11-01/bmo
Earnings (Next)02-28 2026-02-28/bmo
Inst Owners26.93%
Inst Owner ChangeN/A
Ins Owners37.74%
Ins Owner ChangeN/A
Market Cap614.09M
Revenue(TTM)372.13B
Net Income(TTM)67.46B
Analysts44
Price Target441.06 (3.43%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.5%
Min EPS beat(2)0.19%
Max EPS beat(2)4.81%
EPS beat(4)3
Avg EPS beat(4)9.5%
Min EPS beat(4)-9.78%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)8.01%
EPS beat(12)8
Avg EPS beat(12)5.87%
EPS beat(16)12
Avg EPS beat(16)8.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)0.72%
Revenue beat(4)1
Avg Revenue beat(4)-1.43%
Min Revenue beat(4)-4.09%
Max Revenue beat(4)0.72%
Revenue beat(8)3
Avg Revenue beat(8)-1.35%
Revenue beat(12)5
Avg Revenue beat(12)-0.47%
Revenue beat(16)6
Avg Revenue beat(16)-0.84%
PT rev (1m)-1.51%
PT rev (3m)-2.36%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)0.71%
EPS NY rev (1m)0%
EPS NY rev (3m)2.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.01 | ||
| Fwd PE | 0.02 | ||
| P/S | 0 | ||
| P/FCF | 0.04 | ||
| P/OCF | 0.02 | ||
| P/B | 0 | ||
| P/tB | 0 | ||
| EV/EBITDA | 0.64 |
EPS(TTM)28729.65
EY6736.93%
EPS(NY)28100.59
Fwd EY6589.42%
FCF(TTM)11360.1
FCFY2663.88%
OCF(TTM)23158.7
OCFY5430.58%
SpS218742.36
BVpS410385.87
TBVpS340058
PEG (NY)N/A
PEG (5Y)0
Graham Number515054
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.5% | ||
| ROE | 9.66% | ||
| ROCE | 5.61% | ||
| ROIC | 4.53% | ||
| ROICexc | 4.87% | ||
| ROICexgc | 5.82% | ||
| OM | 16.72% | ||
| PM (TTM) | 18.13% | ||
| GM | 17.71% | ||
| FCFM | 5.19% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexgc growth 3Y9.15%
ROICexgc growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 6.58 | ||
| Debt/EBITDA | 1.69 | ||
| Cap/Depr | 151.95% | ||
| Cap/Sales | 5.39% | ||
| Interest Coverage | 12.22 | ||
| Cash Conversion | 52.22% | ||
| Profit Quality | 28.65% | ||
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.11 | ||
| Altman-Z | 1.36 |
F-Score4
WACC3.22%
ROIC/WACC1.41
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.97%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%33.51%
EPS Next Y-0.33%
EPS Next 2Y0.31%
EPS Next 3Y1.09%
EPS Next 5Y2.26%
Revenue 1Y (TTM)0.6%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%2.13%
Revenue Next Year0.8%
Revenue Next 2Y0.25%
Revenue Next 3Y1.4%
Revenue Next 5Y4.89%
EBIT growth 1Y15.71%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.02%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-12.66%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%
BERKSHIRE HATHAWAY INC-CL B / BRYN.DE FAQ
Can you provide the ChartMill fundamental rating for BERKSHIRE HATHAWAY INC-CL B?
ChartMill assigns a fundamental rating of 5 / 10 to BRYN.DE.
What is the valuation status of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?
ChartMill assigns a valuation rating of 8 / 10 to BERKSHIRE HATHAWAY INC-CL B (BRYN.DE). This can be considered as Undervalued.
What is the profitability of BRYN stock?
BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) has a profitability rating of 7 / 10.
What are the PE and PB ratios of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?
The Price/Earnings (PE) ratio for BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is 0.01 and the Price/Book (PB) ratio is 0.
How financially healthy is BERKSHIRE HATHAWAY INC-CL B?
The financial health rating of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is 5 / 10.